Benzinga | Oct 6, 2021 04:33PM EDT

EXCLUSIVE: Ginkgo Bioworks CEO Responds To Short Seller Reports, Says Claim Co. Platform Is A Place For New Startups To Secure Capital, Launch Quickly Is Not A Problem

Here is the statement from the company CEO, Jason Kelly

"Our focus at Ginkgo is increasing the scale of our platform so we can deliver more cell programs to customers. We were doing that yesterday, we'reHere is the statement from the company CEO, Jason Kelly

"Our focus at Ginkgo is increasing the scale of our platform so we can deliver more cell programs to customers. We were doing that yesterday, we're doing it today, and we'll be doing it tomorrow. One thing the report today criticizes is that new startups are launching programs on Ginkgo's platform and leveraging Ginkgo to secure capital, get resources, and launch their new company quickly. We don't think that is a problem -- starting a biotech company should be as easy as launching a website! We're happy we make it easy for companies to start on Ginkgo's platform and hopefully more entrepreneurs hear about our platform today."